Stockreport

OptimizeRx Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]

OptimizeRx Corporation  (OPRX) 
NASDAQ:AMEX Investor Relations: optimizerx.com/investors
PDF Net loss: US$4.01m (loss narrowed by 3.7% from 2Q 2023). US$0.22 loss per share (improved from US$0.24 loss in 2Q 2023). All figures shown in the chart above are fo [Read more]